This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...

Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

These findings indicate that PSP pathology affects gait control pathways that are also affected in PD. Gait changes associated with defective scaling of stride length and postural instability were ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...

The UK charity, PSPA, which has its head office in Milton Keynes, is hosting a free online masterclass on 25 March to help ophthalmic professionals understand Progressive Supranuclear Palsy (PSP) and ...

Progressive supranuclear palsy is a rare progressive and adult-onset neurodegenerative disease that currently has no disease-modifying drug. Approximately seven in 100,000 people worldwide is affected ...

We at CurePSP extend our heartfelt support to Rev. Jesse L. Jackson, Sr., his family and the entire community of individuals who have been touched by his lifelong pursuit of justice and equity. News ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (AMLX) (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the decision to discontinue ...